Vista simple de metadatos

dc.contributorUniv Mayor, Ctr Exercise Physiol Res CIFE, Chilees
dc.contributor.authorPetermann-Rocha, Fanny
dc.contributor.authorHanlon, Peter
dc.contributor.authorGray, Stuart R.
dc.contributor.authorWelsh, Paul
dc.contributor.authorGill, Jason M. R.
dc.contributor.authorFoster, Hamish
dc.contributor.authorKatikireddi, S. Vittal
dc.contributor.authorLyall, Donald
dc.contributor.authorMackay, Daniel F.
dc.contributor.authorO'Donnell, Catherine A.
dc.contributor.authorSattar, Naveed
dc.contributor.authorNicholl, Barbara I.
dc.contributor.authorPell, Jill P.
dc.contributor.authorJani, Bhautesh D.
dc.contributor.authorHo, Frederick K.
dc.contributor.authorMair, Frances S.
dc.contributor.authorCelis-Morales, Carlos A. [Univ Mayor, Ctr Exercise Physiol Res CIFE, Chile]
dc.date.accessioned2022-02-28T21:51:55Z
dc.date.available2022-02-28T21:51:55Z
dc.date.issued2020-11
dc.identifier.citationPetermann-Rocha, F., Hanlon, P., Gray, S. R., Welsh, P., Gill, J. M., Foster, H., ... & Celis-Morales, C. (2020). Comparison of two different frailty measurements and risk of hospitalisation or death from COVID-19: findings from UK Biobank. BMC medicine, 18(1), 1-9.es
dc.identifier.issn1741-7015
dc.identifier.otherWOS: 000591822900001
dc.identifier.otherPMID: 33167965
dc.identifier.urihttp://repositorio.umayor.cl/xmlui/handle/sibum/8369
dc.identifier.urihttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652674/pdf/12916_2020_Article_1822.pdf
dc.identifier.urihttps://bmcmedicine.biomedcentral.com/track/pdf/10.1186/s12916-020-01822-4.pdf
dc.identifier.urihttps://dx.doi.org/10.1186%2Fs12916-020-01822-4
dc.identifier.urihttp://repositorio.ucm.cl/handle/ucm/3540
dc.identifier.urihttp://eprints.gla.ac.uk/225755/1/225755.pdf
dc.description.abstractBackground Frailty has been associated with worse prognosis following COVID-19 infection. While several studies have reported the association between frailty and COVID-19 mortality or length of hospital stay, there have been no community-based studies on the association between frailty and risk of severe infection. Considering that different definitions have been identified to assess frailty, this study aimed to compare the association between frailty and severe COVID-19 infection in UK Biobank using two frailty classifications: the frailty phenotype and the frailty index. Methods A total of 383,845 UK Biobank participants recruited 2006-2010 in England (211,310 [55.1%] women, baseline age 37-73 years) were included. COVID-19 test data were provided by Public Health England (available up to 28 June 2020). An adapted version of the frailty phenotype derived by Fried et al. was used to define frailty phenotype (robust, pre-frail, or frail). A previously validated frailty index was derived from 49 self-reported questionnaire items related to health, disease and disability, and mental wellbeing (robust, mild frailty, and moderate/severe frailty). Both classifications were derived from baseline data (2006-2010). Poisson regression models with robust standard errors were used to analyse the associations between both frailty classifications and severe COVID-19 infection (resulting in hospital admission or death), adjusted for sociodemographic and lifestyle factors. Results Of UK Biobank participants included, 802 were admitted to hospital with and/or died from COVID19 (323 deaths and 479 hospitalisations). After analyses were adjusted for sociodemographic and lifestyle factors, a higher risk of COVID-19 was observed for pre-frail (risk ratio (RR) 1.47 [95% CI 1.26; 1.71]) and frail (RR 2.66 [95% CI 2.04; 3.47]) individuals compared to those classified as robust using the frailty phenotype. Similar results were observed when the frailty index was used (RR mildly frail 1.46 [95% CI 1.26; 1.71] and RR moderate/severe frailty 2.43 [95% CI 1.91; 3.10]). Conclusions Frailty was associated with a higher risk of severe COVID-19 infection resulting in hospital admission or death, irrespective of how it was measured and independent of sociodemographic and lifestyle factors. Public health strategies need to consider the additional risk that COVID-19 poses in individuals with frailty, including which additional preventive measures might be required.es
dc.description.sponsorshipUK Biobank was established by the Wellcome Trust medical charity, Medical Research Council, Department of Health, Scottish Government, and Northwest Regional Development Agency. It has also had funding from the Welsh Assembly Government and the British Heart Foundation. All authors had final responsibility for submission for publication. F.P-R receives financial support from the Chilean Government for doing her PhD (ANID-Becas Chile 2018 -72190067). P.H was funded by a Medical Research Council Clinical Research Training Fellowship MR/S021949/1.es
dc.format.extent9 p., PDFes
dc.language.isoen_USes
dc.publisherBioMed Central Ltd.es
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chilees
dc.titleComparison of two different frailty measurements and risk of hospitalisation or death from COVID-19: findings from UK Biobankes
dc.typeArtículo o Paperes
umayor.indizadorCOTes
umayor.politicas.sherpa/romeoLicencia CC BY 4.0. Disponible en: https://v2.sherpa.ac.uk/id/publication/2442es
umayor.indexadoWeb of Sciencees
umayor.indexadoDOAJes
umayor.indexadoPUBMEDes
umayor.indexadoRepositorio U. Católica del Maule
dc.identifier.doi10.1186/s12916-020-01822-4
umayor.indicadores.wos-(cuartil)Q1
umayor.indicadores.scopus-(scimago-sjr)SCIMAGO/ INDICE H: 138 H
umayor.indicadores.scopus-(scimago-sjr)SJR 3.46


Vista simple de metadatos



Modificado por: Sistema de Bibliotecas Universidad Mayor - SIBUM
DSpace software copyright © 2002-2018  DuraSpace